Home

DOROTHY E PUHY

CIK 1200493 · last filed 2026-06-12

DOROTHY E PUHY is a corporate insider who has filed 131 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider was granted $185.3K of MDXG on Jun 12, 2026. Across all open-market trades the lifetime net is −$20.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $608.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$608.8K

Companies

4

Total Filings

131

Lifetime Open-Market Net

-$20.32M

Filer Profile

Reported Address
DANA FARBER CANCER INSTITUTE
44 BINNEY STREET, RM. D1632
BOSTON, MA 02115
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MDXG Director 108,510 $4.57 $495.9K $0 3 2026-06-12
AZTA Director 3,604 $31.33 $112.9K $0 1 2023-02-15
ABIOMED INC (ABMD) Delisted Director 14,968 $381.02 $5.70M -$13.29M 13 2022-08-12
ABIOMED INC (APOL) Delisted Director 32,749 — — -$7.02M 33 2016-12-14

Recent Filings

131 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 MDXG Grant (A) +50,913 $185.3K EDGAR
2025-06-23 MDXG Grant (A) +28,609 $185.1K EDGAR
2024-06-06 MDXG Grant (A) +28,988 $210.5K EDGAR
2024-02-14 AZTA Notice (144) −3,604 -$237.9K EDGAR
2023-02-15 AZTA Grant (A) +3,604 $0 EDGAR
2022-12-27 — Disp (D) −14,590 $0
2022-08-12 ABIOMED INC (ABMD) Delisted Mixed +418 -$77.1K EDGAR
2021-08-13 ABIOMED INC (ABMD) Delisted Mixed +346 -$89.2K EDGAR
2021-03-03 — Disp (D) −23,981 $0
2021-02-16 — Grant (A) — $0
Showing 1–10 of 131
Page 1 of 14
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.